期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 12, 期 8, 页码 491-498出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrclinonc.2015.62
关键词
-
类别
资金
- NCI grants [5U01CA141457-05, 5U01CA141496-05]
Owing to the molecular complexity of cancer and the cost of therapy, researchers have begun looking to in vivo functional genomics to inform patient care. Unfortunately, xenographs of established tumour cell lines in immunodeficient mice fail to recapitulate many critical features of human primary tumours. By contrast, mouse models of cancer often faithfully recapitulate basic biology, tumour-microenvironment interactions, drug responses and therapy resistance similar to human disease. Thus, we established the co-clinical trial project, and in doing so developed the concept of the mouse hospital, whereby in vivo preclinical and early clinical studies are closely aligned, enabling in vivo testing of drugs in a multitude of cancer subtypes using mouse models, while minimizing the cost and time required to study responses in thousands of human patients. This approach can inform enrolment of patients in clinical trials, and can enable repositioning and/or repurposing of previously approved drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据